Method of selecting hla-dp4 ligands and the applications thereof
CA 2463705 A1 · Owner: Maillere, Bernard · Inventors: Buhot, Cecile; Castelli, Florence; Maillere, Bernard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method of selecting HLA-DP4 ligand molecules comprising the following steps: (i) incubation of purified HLA-DP4 with a tracer having general formula (I) Z¿1?X¿1?X¿2?X¿3?X¿4?X¿5?X¿6?X¿7?X¿8?X¿9?Z¿2? (wherein Z¿1? and Z¿2? which may be identical or different, are equal to zero or each represent a peptide with between 1 and 100 amino acids; X¿6? represents an aromatic or hydrophobic amino acid or a cysteine; and X¿1? represents an aromatic or hydrophobic amino acid and/or X¿9? represents an aromatic or hydrophobic amino acid or C D, Q, S, T or E; and X¿2?,X¿3?,X¿4?,X¿5?,X¿7? and X¿8? each represent an amino acid) in the presence of different concentrations of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 17, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 17, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 17, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.